Purchase Order 75D30120P08970

The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a $75,680 firm fixed price purchase order to Premier Medical USA Corporation of Plainfield, NJ for the delivery of SURESTATUS HIV-1 RECENCY CARD TEST AND FIRST RESPONSE HIV 1-2.O CARD TEST (VERSION 2.0). The tests will help the CDC monitor and track HIV infection rates as part of its efforts to prevent and treat HIV/AIDS. No set-aside designation was used for this award. Premier Medical...

This firm fixed price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Sedia Biosciences Corporation, doing business as Sedia Biosciences Corp, for the provision of Asante HIV-1 Rapid Recency Assay kits. The $77,950.00 contract supports CDC disease surveillance and prevention initiatives, with the kits being delivered to the CDC's Pittsburgh, Pennsylvania facility. Sedia Biosciences Corp has previously received over $350,000 in CDC purchase orders for similar...

The Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order to Sedia Biosciences Corporation, a privately held medical device and diagnostics company, to provide Asante HIV-1 Rapid Recency Assays and HIV-1 LAg-Avidity EIA Avidity Kits. The $119,155.00 contract was awarded on September 3, 2020, with a completion date of April 15, 2021. These products are used in the CDC's ongoing HIV surveillance program and are only available from Sedia Biosciences Corporation....

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Sr-Services GMBH, a German-based for-profit company that specializes in providing medical technology, procurement services, and medical equipment, devices, and consumables to U.S. government agencies. The contract is for the delivery of 4,568,003,214 units of the ORAQUICK RP HIV1/2 25S diagnostic test kit, with a ceiling value of $1,406.99. The contract has an ultimate completion date...

The Centers for Disease Control and Prevention awarded a firm fixed-price purchase order to Roche Diagnostics Corporation on August 5, 2024, for biomedical reagents and testing supplies required to conduct HIV molecular laboratory testing. The contract ceiling value is $25,725.24, with an ultimate completion date of September 30, 2024. This sole-source procurement was issued without a set-aside designation and supports PEPFAR (President's Emergency Plan for AIDS Relief)-supported field...

This contract award to Roche Diagnostics Corporation (Roche) is for the COBAS AMPLIPREP TAQMAN HIV-1 TEST V 2.0. The contract, which has a ceiling value of $109,459.97, was awarded by the U.S. Army Medical Command (MEDCOM) for the delivery of this diagnostic test and is a firm fixed price Blanket Purchase Agreement (BPA) call. The contract does not have a set-aside designation. Roche is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated...

This is a federal contract award by the Defense Logistics Agency (DLA) Troop Support Medical to Sr-Services GMBH, a German-based for-profit company that specializes in providing medical technology, procurement services, and a comprehensive range of medical equipment, devices, consumables, and related services to U.S. government agencies. The contract is for the delivery of 4,568,017,554 units of ORAQUICK RP HIV1/2 25S medical diagnostic test kits, with a ceiling value of $1,238.00. The...

This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Roche Diagnostics Corporation for the COBAS TAQMAN HIV-1 TEST. The $12,054.00 firm fixed price purchase order does not have a set-aside designation. Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics and related products, has a history of providing critical care analyzers, reagents, test kits, and associated equipment and supplies to various...

This $109,459.97 firm fixed price BPA call was awarded to Roche Diagnostics Corporation by the U.S. Army Medical Command to provide COBAS AMPLIPREP TAQMAN HIV-1 TEST V 2.0 products and services. Roche is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The award is for the delivery of HIV-1 testing products and is not part of a set-aside program. Roche has previously received awards from federal agencies such as the...

This contract was awarded by the Department of the Army Medical Command to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $124,693.14 firm fixed price contract is for HIV-1 TEST V2.0 PN#5212308190, with a completion date of March 6, 2020. The contract was not set aside for any particular business type. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and...